share_log

Teachers Retirement System of The State of Kentucky Sells 22,248 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII)

Teachers Retirement System of The State of Kentucky Sells 22,248 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII)

肯塔基州教師退休系統出售22,248股心血管系統公司(納斯達克代碼:CSII)
Defense World ·  2022/09/28 04:31

Teachers Retirement System of The State of Kentucky lessened its holdings in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 68.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,100 shares of the medical device company's stock after selling 22,248 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in Cardiovascular Systems were worth $228,000 as of its most recent filing with the SEC.

肯塔基州教師退休系統公司在提交給美國證券交易委員會的最新Form 13F文件中稱,該公司第一季度減持了68.8%的心血管系統公司股票。該公司在此期間出售了22,248股票後,擁有這家醫療器械公司的10,100股票。肯塔基州教師退休制度截至最近提交給美國證券交易委員會的文件,肯塔基州持有的心血管系統公司價值228,000美元。

Several other institutional investors also recently modified their holdings of CSII. Cubist Systematic Strategies LLC grew its stake in shares of Cardiovascular Systems by 1,124.7% in the fourth quarter. Cubist Systematic Strategies LLC now owns 176,858 shares of the medical device company's stock worth $3,321,000 after purchasing an additional 162,417 shares during the last quarter. Grandeur Peak Global Advisors LLC grew its stake in shares of Cardiovascular Systems by 36.2% in the fourth quarter. Grandeur Peak Global Advisors LLC now owns 564,582 shares of the medical device company's stock worth $10,603,000 after purchasing an additional 150,103 shares during the last quarter. Federated Hermes Inc. bought a new stake in shares of Cardiovascular Systems in the first quarter worth $2,697,000. Royal Bank of Canada lifted its holdings in Cardiovascular Systems by 89.0% in the first quarter. Royal Bank of Canada now owns 187,700 shares of the medical device company's stock valued at $4,242,000 after buying an additional 88,376 shares during the period. Finally, BlackRock Inc. lifted its holdings in Cardiovascular Systems by 1.1% in the first quarter. BlackRock Inc. now owns 7,087,402 shares of the medical device company's stock valued at $160,176,000 after buying an additional 80,138 shares during the period. Institutional investors own 91.72% of the company's stock.

其他幾家機構投資者最近也調整了對中證二號的持股。Cubist Systems Strategy LLC第四季度在心血管系統公司的股份增加了1124.7%。Cubist Systems Strategy LLC在上個季度額外購買了162,417股後,現在擁有176,858股這家醫療設備公司的股票,價值3,321,000美元。宏偉高峯全球顧問有限責任公司第四季度在心血管系統公司的持股增加了36.2%。宏偉的Peak Global Advisors LLC現在擁有564,582股這家醫療設備公司的股票,價值10,603,000美元,在上個季度又購買了150,103股。今年第一季度,聯合愛馬仕公司購入了價值269.7萬美元的心血管系統新股。加拿大皇家銀行在第一季度增持心血管系統89.0%。加拿大皇家銀行現在持有這家醫療器械公司187,700股股票,價值4,242,000美元,在此期間又購買了88,376股。最後,貝萊德股份有限公司在第一季度增持了心血管系統公司的股份1.1%。貝萊德股份有限公司目前持有這家醫療器械公司7,087,402股股票,價值160,176,000美元,在此期間又購買了80,138股。機構投資者持有該公司91.72%的股票。

Get
到達
Cardiovascular Systems
心血管系統
alerts:
警報:

Cardiovascular Systems Price Performance

心血管系統性價比

CSII stock opened at $13.30 on Wednesday. The firm has a market cap of $544.83 million, a price-to-earnings ratio of -14.00 and a beta of 0.97. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08. Cardiovascular Systems, Inc. has a 12-month low of $12.51 and a 12-month high of $36.97. The company's fifty day simple moving average is $14.86 and its 200 day simple moving average is $16.62.

CSII股票週三開盤報13.30美元。該公司市值為5.4483億美元,市盈率為-14.00倍,貝塔係數為0.97。該公司的速動比率為5.19,流動比率為6.05,債務權益比率為0.08。心血管系統公司的股價為12.51美元的12個月低點和36.97美元的12個月高位。該公司的50日簡單移動均線切入位為14.86美元,200日簡單移動均線切入位為16.62美元。

Cardiovascular Systems Profile

心血管系統概況

(Get Rating)
(獲取評級)

Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.

心血管系統公司是一家醫療技術公司,在美國和國際上開發和銷售治療外周和冠狀動脈疾病的解決方案。該公司提供外周動脈疾病產品,包括基於導管的平臺,用於治療膝蓋以上和膝蓋以下的各種斑塊類型,包括鈣化斑塊,以及解決與手術、導管和藥物治療替代方案相關的各種限制;以及外周支持產品。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
  • Defensive Stocks For A Volatile Market
  • Will UPS Be Next to Deliver a Warning?
  • SunPower Is Ready To Power Up Triple-Digit Earnings Gains
  • Is This the Darkest Before the Dawn for Gap Stock?
  • Build A Better Tech Portfolio With Jabil Inc.
  • 免費獲取StockNews.com心血管系統研究報告(CSII)
  • 防禦性股票應對動盪的市場
  • UPS會成為下一個發出警告的公司嗎?
  • SunPower準備推動三位數的收益增長
  • 這是Gap Stock黎明前最黑暗的一次嗎?
  • 與捷普公司一起打造更好的技術產品組合。

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating).

想看看其他對衝基金持有哪些中證指數嗎?訪問HoldingsChannel.com獲取心血管系統公司(納斯達克代碼:CSII-GET評級)的最新13F申報文件和內幕交易信息。

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受《每日心血管系統》新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對心血管系統和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論